NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/04/2026
Back to search
Official data from USPTO
BELESALA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
06/05/2026
Trademark type
Word
Nice classes
5, 10
Filing date
09/10/2019
Registration date
10/27/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/27/2020
Last transaction
06/05/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
77
Owner location
IE
Examiner
JAGANNATHAN, SIDDHARTH
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Mallinckrodt Pharmaceuticals Ireland Limited
Representatives
Camille M. Miller Cozen O'Connor
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of neurological diseases and disordersnephrotic diseasesendocrine disordersrheumatic disorderscollagen diseasesdermatologic diseases and disordersallergic statesophthalmic diseasesrespiratory diseaseshematologic disordersneoplastic diseasesedematous stategastrointestinal diseaseshepatic diseases and disordersbiliary diseases and disordersrenal disorderscardiovascular and lipid-related diseases and disordersinflammatory and autoimmune diseases and disorders; intravenous analgesics and antipyretics; syringes sold prefilled with pharmaceutical preparations for the treatment of neurological diseases and disordersnephrotic diseasesendocrine disordersrheumatic disorderscollagen diseasesdermatologic diseases and disordersallergic statesophthalmic diseasesrespiratory diseaseshematologic disordersneoplastic diseasesedematous stategastrointestinal diseaseshepatic diseases and disordersbiliary diseases and disordersrenal disorderscardiovascular and lipid-related diseases and disordersinflammatory and autoimmune diseases and disordersintravenous analgesics and antipyretics
Class 10
Medical apparatus and instruments for use in connection with the administration of gases to patients for medical and therapeutic purposes and accessories and parts thereofmedical and therapeutic gas delivery systems comprised primarily of gas cylindersvalvesregulatorsflow metersdelivery hoses and apparatus and instruments for settingmeasuring and regulating the mixture of medical and therapeutic gases delivered to patients; therapeutic medical device and accessories and parts thereof for extracting blood from the bodyseparating bloodtreating it extracorporallyreturning it to the body used for extracorporeal photopheresisextracorporeal photo immune therapyextracorporeal photo chemotherapycellular therapies; medical devicemedical syringes used for manual injection
Publications
History of USPTO decisions and trademark events.
35 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/13/2026
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/13/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/13/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/13/2026
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
10/27/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/21/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/04/2021
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
02/11/2021
XXCR
GENERIC MADRID TRANSACTION CREATED
02/11/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/27/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
10/27/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/11/2020
PUBO
PUBLISHED FOR OPPOSITION
08/11/2020
GPNX
NOTIFICATION PROCESSED BY IB
08/07/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/22/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/22/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/22/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/07/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
07/07/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/07/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
07/07/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/07/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/06/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/06/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/06/2020
RFNT
REFUSAL PROCESSED BY IB
02/08/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/21/2020
RFRR
REFUSAL PROCESSED BY MPU
01/21/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/12/2019
CNRT
NON-FINAL ACTION WRITTEN
12/11/2019
DOCK
ASSIGNED TO EXAMINER
12/11/2019
MAFR
APPLICATION FILING RECEIPT MAILED
12/10/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/06/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/05/2019
Continuous trademark protection
Get notified about every new filing that threatens BELESALA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.